Get started
Author

Jose-Lázaro Pérez-Calle

Observed names: J.L. Pérez-Calle, Jose‐Lázaro Pérez‐Calle, José L´zaro Pérez-Calle, José Lázaro Pérez‐Calle
OpenAlex ID: A5111827032
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
2009 · Javier P. Gisbert, Fernando Bermejo, et al. · Inflammatory Bowel Diseases · 320
Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement
2009 · Javier P. Gisbert, Fernando Bermejo, et al. · Inflammatory Bowel Diseases · 147
Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain
2022 · Xavier Calvet, Julián Panés, et al. · Journal of Crohn s and Colitis · 22
PDF
Impact of Prior Biologic Mechanism of Action on Anti‐ TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study
2026 · Carmen Yagüe Caballero, Santiago García López, et al. · Alimentary Pharmacology & Therapeutics · 4
PDF
Adaptation of the International Consortium for Health Outcomes Measurement Standard Set for Inflammatory Bowel Disease for Routine Collection in Clinical Practice
2026 · Xavier Calvet, Iago Rodríguez‐Lago, et al. · JCC Plus
P157 - Intensification of infliximab (IFX) therapy in Crohn's disease: efficacy and safety
2009 · M. Chaparro, P. Martínez-Montiel, et al. · Journal of Crohn s and Colitis
Works count: 6
Citation count: 493
H-index: 4
I10-index: 3
Year
Topic
Type